News & Commentary
Latest News Features
Latest News Videos
Moving the Market |
|
Market Summary | | Stocks On The Move |
6/19/2013 8:31 AM ET
[BRIEFING.COM] [BRIEFING.COM] S&P futures vs fair value: -0.20. Nasdaq futures vs fair value: +3.00. The S&P 500 futures continue to alternate between slim gains and losses while Nasdaq futures trade higher by 0.2%. Adobe Systems (ADBE...[more]
Stock Market Headlines
ChemoCentryx Announces Completion of Target Enrollment of CCX140 Phase II Clinical Trial in Diabeti 8:30AM ET - GlobeNewswire
PDC Energy Announces Closing of Non-Core Colorado Natural Gas Asset Sale; Proceeds to Accelerate De 8:30AM ET - GlobeNewswire
Biodel Prices Public Offering of Common Stock 8:30AM ET - GlobeNewswire
Aerospace Technologies Group Inc. Announces Introduction of Tranquility Shade System: Electronicall 8:30AM ET - GlobeNewswire
FedEx 4th-Quarter Net Falls 45% on Charges; Gives Downbeat Year View 8:14AM ET - Dow Jones Business News
View AllBrowse News by Category
RSS user?
Market Musings
Market Currents
Real-time news and commentary for investors
- 8:38 AM Vanda Pharmaceuticals (VNDA) sinks 14% premarket after Adam Feuerstein raises questions about the design of the company's Phase 3 trial for Tasimelteon ( previous) which he says has "changed numerous times." Specifically, Feuerstein notes that the company changed the primary endpoint to a measure it created which "has never been used before in sleep-drug clinical trials [and is not ] endorsed by the FDA."
- See All Market Currents